| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
35,027 |
33,970 |
$1.62M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17,106 |
16,562 |
$1.05M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,632 |
6,617 |
$490K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
9,640 |
9,500 |
$456K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
5,642 |
5,637 |
$435K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12,714 |
12,552 |
$360K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14,719 |
14,639 |
$260K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,263 |
3,251 |
$248K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
24,769 |
24,550 |
$234K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
22,336 |
22,212 |
$227K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,528 |
880 |
$189K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,164 |
6,383 |
$154K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
7,170 |
6,963 |
$142K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
5,710 |
5,640 |
$133K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
778 |
777 |
$104K |
| 99173 |
|
6,037 |
6,009 |
$101K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,023 |
985 |
$87K |
| 90834 |
Psychotherapy, 45 minutes with patient |
943 |
652 |
$86K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
5,356 |
5,333 |
$86K |
| 92587 |
|
9,137 |
4,638 |
$77K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
848 |
835 |
$66K |
| 96127 |
|
4,209 |
4,193 |
$42K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,023 |
5,973 |
$42K |
| 99051 |
|
2,241 |
2,223 |
$30K |
| 99215 |
Prolong outpt/office vis |
183 |
169 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,875 |
1,849 |
$22K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
397 |
374 |
$21K |
| 99188 |
|
780 |
775 |
$20K |
| 83655 |
|
1,413 |
1,401 |
$17K |
| 0001A |
|
334 |
334 |
$15K |
| 0002A |
|
306 |
306 |
$14K |
| 0071A |
|
301 |
300 |
$14K |
| 0072A |
|
287 |
287 |
$13K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
402 |
398 |
$11K |
| 90686 |
|
10,742 |
10,716 |
$11K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
389 |
386 |
$11K |
| 94760 |
|
4,682 |
4,509 |
$10K |
| 99401 |
|
310 |
307 |
$9K |
| 0011A |
|
181 |
181 |
$7K |
| 0012A |
|
131 |
131 |
$6K |
| 90651 |
|
782 |
781 |
$5K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
48 |
48 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
38 |
38 |
$3K |
| 81003 |
|
1,332 |
1,292 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
59 |
57 |
$2K |
| 99050 |
|
157 |
157 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
12 |
12 |
$2K |
| 81002 |
|
693 |
682 |
$2K |
| 0003A |
|
35 |
35 |
$2K |
| 87634 |
|
25 |
25 |
$2K |
| 90480 |
|
26 |
26 |
$1K |
| 90461 |
|
156 |
141 |
$1K |
| 0124A |
|
24 |
24 |
$1K |
| 0082A |
|
17 |
17 |
$779.79 |
| 98966 |
|
69 |
67 |
$743.13 |
| 0073A |
|
14 |
14 |
$642.18 |
| 0083A |
|
14 |
14 |
$642.18 |
| 90832 |
Psychotherapy, 30 minutes with patient |
12 |
12 |
$626.40 |
| 0081A |
|
13 |
13 |
$596.31 |
| 0074A |
|
13 |
13 |
$596.31 |
| 90734 |
|
506 |
505 |
$525.43 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
15 |
15 |
$433.30 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
29 |
27 |
$412.02 |
| 90620 |
|
27 |
27 |
$302.82 |
| 90715 |
|
58 |
57 |
$194.89 |
| 90474 |
|
14 |
14 |
$137.76 |
| 90656 |
|
274 |
273 |
$111.75 |
| 99177 |
|
420 |
420 |
$104.16 |
| 99174 |
|
13 |
12 |
$90.30 |
| 86308 |
|
12 |
12 |
$42.48 |
| 90670 |
|
401 |
401 |
$0.00 |
| 90633 |
|
347 |
346 |
$0.00 |
| 91300 |
|
779 |
746 |
$0.00 |
| 90648 |
|
248 |
248 |
$0.00 |
| 99072 |
|
196 |
195 |
$0.00 |
| 90710 |
|
25 |
25 |
$0.00 |
| 91308 |
|
89 |
87 |
$0.00 |
| 91312 |
|
24 |
24 |
$0.00 |
| 36416 |
|
2,606 |
2,595 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
1,240 |
1,197 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
2,255 |
2,252 |
$0.00 |
| 99000 |
|
861 |
848 |
$0.00 |
| 0154A |
|
13 |
13 |
$0.00 |
| 90680 |
|
64 |
64 |
$0.00 |
| 90697 |
|
12 |
12 |
$0.00 |
| 91301 |
|
308 |
308 |
$0.00 |
| 90723 |
|
92 |
92 |
$0.00 |
| 90696 |
|
25 |
25 |
$0.00 |
| 91307 |
|
685 |
661 |
$0.00 |
| 90619 |
|
52 |
52 |
$0.00 |
| 91315 |
|
26 |
13 |
$0.00 |